DREAMM12
A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Varying Degrees of Impaired Renal Function
Filters
Save & Share
Clear Filters
Location
Explore options near your patient - or anywhere in the US.
Diagnosis
Treatment History
BCMA Therapy
This stands for B Cell Maturation Antigen (BCMA) and includes treatments such as ide-cel, cilta-cel or belantamab mafodotin.
Near Add Your Location
Sort by
Beverly Hills Cancer Center
Beverly Hills, CA
- Accepting patients
- Show Principal Investigator
Boca Raton Clinical Research (BRCR) Medical Center
Plantation, FL
- Accepting patients
- Show Principal Investigator
University of Kansas Cancer Center
Kansas City, KS
- Accepting patients
- Show Principal Investigator
Banner Health University Medical Center
Tucson, AZ
- Accepting patients
- Show Principal Investigator
Mayo Clinic (Jacksonville)
Jacksonville, FL
- Accepting patients
- Show Principal Investigator
- Accepting patients
- Show Principal Investigator
- Accepting patients
- Show Principal Investigator
Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine
Chicago, IL
- Accepting patients
- Show Principal Investigator
John Theurer Cancer Center at Hackensack University Medical Center
Hackensack Meridian Health
Hackensack, NJ
- Accepting patients
- Show Principal Investigator
- Accepting patients
- Show Principal Investigator
1,344 hidden based on your filters. Show All
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.